摘要
先天性心脏病(先心病)介入治疗在我国已有40年发展历程,经历了从学习改进到自主创新的沧桑变化,见证了我国介入治疗体系从无到有,逐渐达到世界领先规模和水平的辉煌成就。随着介入治疗技术与器械的不断发展,新的理念和观点不断被我们探讨研究。本文就介入治疗技术发展及介入治疗器械发展两方面进行阐述,对我国常见先心病的介入治疗进行系统性回顾,以期为其进一步发展提供借鉴与经验。
Transcatheter intervention for congenital heart disease has been developed for 40 years in China,it has experienced the transition of learning to self-dependent innovation,and witnessed the intervention therapy system starting from scratch and gradually reaching the top level and gaining high achievements in the world scale.With the continuous development of interventional technology and devices,cutting-edge ideas and viewpoints are constantly discussed.This review summarized the development of intervention techniques and devices,hoping to provide some experience for the further development of transcatheter interventions for congenial heart disease.
作者
闫一鸣
欧阳文斌
张凤文
房芳
潘湘斌
YAN Yiming;OUYANG Wenbin;ZHANG Fengwen;FANG Fang;PAN Xiangbin(Department of Structural Heart Disease,National Center for Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing,100037,P.R.China;National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine,Beijing,100037,P.R.China;Key Laboratory of Innovative Cardiovascular Devices,Chinese Academy of Medical Sciences,Beijing,100037,P.R.China;National Clinical Research Center for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences,Beijing,100037,P.R.China)
出处
《中国胸心血管外科临床杂志》
CSCD
北大核心
2022年第10期1243-1253,共11页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金
中央级公益性科研院所基本科研业务费(2019PT350005)
国家自然科学基金(81970444)
北京市科技计划(Z201100005420030)
国家高层次人才特殊支持计划(2020-RSW02)
中国医学科学院医学与健康科技创新工程(2021-I2M-1-065)
深圳“三名”工程项目(SZSM202011013)。
关键词
先天性心脏病
介入治疗
封堵器
述评
Congenital heart disease
interventional therapy
occluder device
commentary
